Web Results

en.wikipedia.org/wiki/Abatacept

Abatacept (marketed as Orencia) is a drug used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells. It is a ...

www.orencia.bmscustomerconnect.com

The ORENCIA® (abatacept) site provides Important Safety Information and Full Prescribing Information. Visit orencia.bmscustomerconnect.com to learn more.

www.rheumatology.org/I-Am-A/Patient-Caregiver/Treatments/Abatacept-Orencia

Abatacept (Orencia) is often prescribed after failure of a disease-modifying anti- rheumatic agent (DMARD), like methotrexate but it can be used as first-line ...

www.rxlist.com/orencia-drug.htm

Jul 13, 2017 ... ORENCIA® (abatacept) is a selective T cell costimulation modulator. ORENCIA is a soluble fusion protein that consists of the extracellular ...

www.rheumatology.org/Learning-Center/Medication-Guides/Medication-Guide-Abatacept-Orencia

Abatacept (Orencia) is a biologic reference guide with prescribing information, dosage, medication administration, and possible side effects.

medlineplus.gov/druginfo/meds/a606016.html

Feb 11, 2012 ... Abatacept Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus.

www.medicinenet.com/abatacept/article.htm

Orencia (abatacept) is an injectible man-made protein used for treating rheumatoid arthritis in adults and juvenile idiopathic arthritis in children six years of age ...

www.nejm.org/doi/full/10.1056/NEJMoa050524

Sep 15, 2005 ... Original Article from The New England Journal of Medicine — Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α ...

www.drugbank.ca/drugs/DB01281

May 16, 2007 ... Abatacept is a soluble fusion protein, which links the extracellular domain of human cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) to ...